Company Filing History:
1 out of 31 
1 out of 832,843 Years Active: 2002-2012
Title: Toshiaki Tabata: Innovator in Ocular Therapeutics
Introduction
Toshiaki Tabata is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of ocular therapeutics, particularly in the treatment of diseases associated with apoptotic degeneration in ocular tissue cells. With a total of 2 patents, his work has the potential to impact the lives of many suffering from vision-related ailments.
Latest Patents
One of Toshiaki Tabata's latest patents focuses on therapeutic agents for diseases associated with apoptotic degeneration in ocular tissue cells that utilize SIV-PEDF vectors. This invention provides novel methods for treating such diseases through the effective administration of pigment epithelium derived factor (PEDF). The research conducted by Tabata and his team studied PEDF as a means to prevent ganglion cell death, which is a critical pathology in glaucoma. The invention emphasizes the use of SIV vectors for delivering PEDF effectively, leading to the construction of an SIV-PEDF vector. When administered subretinally in ischemia reperfusion and NMDA-induced models, the SIV-PEDF vector demonstrated a significant suppression effect on ganglion cell death. This discovery positions the SIV-PEDF vector as an effective pharmaceutical agent for treating diseases like glaucoma.
Another notable patent by Tabata involves a DNA sequence that possesses promoter activity of Tec tyrosine kinase. This invention includes a vector that incorporates the promoter, enabling high-level expression of an exogenous gene in hematopoietic stem cells and hepatic cells.
Career Highlights
Throughout his career, Toshiaki Tabata has worked with various organizations, including Dna Vec Research Inc. His innovative research and dedication to advancing ocular therapeutics have established him as a key figure in his field.
Collaborations
Toshiaki Tabata has collaborated with notable individuals such as Mamoru Hasegawa and Masanori Miyazaki. These partnerships have contributed to the success of his research and the development of his patents.
Conclusion
Toshiaki Tabata's work in ocular therapeutics showcases his commitment to innovation and improving patient outcomes. His patents reflect a deep understanding of the complexities of ocular diseases and the potential for novel treatments.